Kitagawa C - Search Results

1

A Randomized Phase II Study Comparing Nivolumab With Carboplatin-Pemetrexed for Patients With EGFR Mutation-Positive Nonsquamous Non-Small-Cell Lung Cancer Who Acquire Resistance to Tyrosine Kinase Inhibitors Not Due to a Secondary T790M Mutation: Rationale and Protocol Design for the WJOG8515L Study.

Hayashi H, Chiba Y, Sakai K, Fujita T, Yoshioka H, Sakai D, Kitagawa C, Naito T, Takeda K, Okamoto I, Mitsudomi T, Kawakami Y, Nishio K, Nakamura S, Yamamoto N, Nakagawa K. Hayashi H, et al. Among authors: kitagawa c. Clin Lung Cancer. 2017 Nov;18(6):719-723. doi: 10.1016/j.cllc.2017.05.012. Epub 2017 May 25. Clin Lung Cancer. 2017. PMID: 28623122 Clinical Trial.

2

Post-Progression Survival after EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations.

Kogure Y, Saka H, Oki M, Saito TI, Ahmed SN, Kitagawa C, Imaizumi K. Kogure Y, et al. Among authors: kitagawa c. PLoS One. 2015 Aug 11;10(8):e0135393. doi: 10.1371/journal.pone.0135393. eCollection 2015. PLoS One. 2015. PMID: 26262682 Free PMC article.

3

A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.

Saka H, Kitagawa C, Ichinose Y, Takenoyama M, Ibata H, Kato T, Takami K, Yamashita M, Maeda T, Takeo S, Ueda H, Okabayashi K, Nagashima S, Oka T, Kouso H, Fukuyama S, Yoshimoto K, Shimokawa M, Saito AM, Ito S. Saka H, et al. Among authors: kitagawa c. Trials. 2017 Sep 15;18(1):429. doi: 10.1186/s13063-017-2103-4. Trials. 2017. PMID: 28915900 Free PMC article. Clinical Trial.

4

Sterilized talc pleurodesis for malignant pleural effusions: a Phase II study for investigational new drug application in Japan.

Saka H, Oki M, Kitagawa C, Kogure Y, Kojima Y, Saito AM, Ishida A, Miyazawa T, Takeda K, Nakagawa K, Sasada S, Negoro S. Saka H, et al. Among authors: kitagawa c. Jpn J Clin Oncol. 2018 Apr 1;48(4):376-381. doi: 10.1093/jjco/hyy020. Jpn J Clin Oncol. 2018. PMID: 29528450 Clinical Trial.

5

Phase II Study of Weekly Amrubicin for Refractory or Relapsed Small Cell Lung Cancer.

Yoshioka H, Kogure Y, Ando M, Kitagawa C, Iwasaku M, Niwa T, Saka H. Yoshioka H, et al. Among authors: kitagawa c. In Vivo. 2018 Nov-Dec;32(6):1581-1586. doi: 10.21873/invivo.11417. In Vivo. 2018. PMID: 30348719 Free PMC article. Clinical Trial.

6

Rationale and Design of a Randomized Phase 2 Trial of Gefitinib Plus Bevacizumab vs Gefitinib Alone in Patients with Epidermal Growth Factor Receptor Mutant Non-Squamous Non-Small-Cell Lung Cancer: Study Protocol.

Kitagawa C, Kada A, Saito AM, Ichinose Y, Saka H. Kitagawa C, et al. Kurume Med J. 2019 May 16;65(2):77-81. doi: 10.2739/kurumemedj.MS652001. Epub 2018 Nov 15. Kurume Med J. 2019. PMID: 30429415 Free article.

7

Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer.

Kitagawa C, Iwasaku M, Kogure Y, Ando M, Yoshioka H, Nishiyama A, Watanabe N, Kunimasa K, Tsubouchi K, Oka S, Saka H. Kitagawa C, et al. In Vivo. 2019 Jan-Feb;33(1):163-166. doi: 10.21873/invivo.11453. In Vivo. 2019. PMID: 30587617 Free PMC article. Clinical Trial.

8

Gefitinib Plus Bevacizumab vs. Gefitinib Alone for EGFR Mutant Non-squamous Non-small Cell Lung Cancer.

Kitagawa C, Mori M, Ichiki M, Sukoh N, Kada A, Saito AM, Ichinose Y. Kitagawa C, et al. In Vivo. 2019 Mar-Apr;33(2):477-482. doi: 10.21873/invivo.11498. In Vivo. 2019. PMID: 30804129 Free PMC article. Clinical Trial.

9

Phase I Study of Carboplatin Plus Pemetrexed with Concurrent Radiotherapy for Locally Advanced Non-Squamous NSCLC (CJLSG0912).

Murata N, Kogure Y, Kondo M, Kitagawa C, Saka H. Murata N, et al. Among authors: kitagawa c. Kurume Med J. 2021 Oct 6;66(3):139-143. doi: 10.2739/kurumemedj.MS663002. Epub 2021 Aug 20. Kurume Med J. 2021. PMID: 34421093 Free article. Clinical Trial.

10

Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer.

Matsumoto Y, Kawaguchi T, Watanabe M, Isa SI, Ando M, Tamiya A, Kubo A, Kitagawa C, Yoshimoto N, Koh Y. Matsumoto Y, et al. Among authors: kitagawa c. BMC Cancer. 2022 Jul 15;22(1):775. doi: 10.1186/s12885-022-09869-7. BMC Cancer. 2022. PMID: 35840951 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters